Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 7/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31028162 | 0.87 | PARP10 (0.47) | SCN9APARP10CTNNB1NCOA1NCOA3 | |
| SCHEMBL31028161 | 0.83 | SCN9A (0.45) | SCN9A | |
| SCHEMBL31028163 | 0.81 | PARP10 (0.42) | SCN9APARP10CTNNB1NCOA1NCOA3 | |
| SCHEMBL31028156 | 0.72 | SCN9A (0.44) | SCN9A | |
| SCHEMBL31028187 | 0.72 | SCN9A (0.43) | SCN9APARP10FEN1 | |
| SCHEMBL31028148 | 0.71 | SCN9A (0.46) | SCN9A | |
| SCHEMBL24578005 | 0.70 | BCAT2 (0.50) | SCN9APARP10CTNNB1FFAR4FFAR1 | |
| SCHEMBL20472992 | 0.70 | CTNNB1 (0.57) | PARP10CTNNB1LMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL27800575 | 0.70 | CTNNB1 (0.77) | SCN9APARP10CTNNB1LMNASMN1; SMN2 | |
| SCHEMBL28500768 | 0.68 | IKBKB (0.51) | SCN9APARP10CTNNB1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113646299-B | Novel N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE 2) receptor modulators | 梅迪比奥法尔玛公司 | 2024-07-26 | — | — | CN | claimed |
| CN-113646299-B | Novel N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE 2) receptor modulators | 梅迪比奥法尔玛公司 | 2024-07-26 | — | — | CN | disclosed |